Epidemiology and issues of NIV-treated AECOPD patients with hypercapnic respiratory failure in Shanghai: A multicentre retrospective survey.
Sheng-Mei WangFeng-Ying ZhangChun-Ling DuXiong-Biao WangFan LiJing-Qing HangYuan-Jing ChenKe-Wen ChengLei ZhaoXiao-Yan JinJin-Dong ShiZhi-Jun JieJie-Ming Qunull nullPublished in: The clinical respiratory journal (2021)
The NIV can be successfully used for AECOP patients in local hospitals of Shanghai, but accompanied by high costs and long hospital stays. However, the treatments for exacerbation and stable COPD patients are still insufficient.